
Loading, please wait...

Loading, please wait...

AIIMS-Delhi has launched a landmark investigation into the growing link between lung cancer air pollution and public health. This initiative, known as the AIRCARE study, represents a first-of-its-kind effort in India to establish scientific evidence regarding environmental carcinogens. Dr. Abhishek Shankar, Assistant Professor of Radiation Oncology at AIIMS, leads the research team. He emphasizes that as air quality continues to decline, understanding its role in disease management becomes a vital necessity for policy development.
The study specifically targets fine particulate matter 2.5 (PM 2.5) as a primary risk factor. India currently houses several of the most polluted cities globally. Consequently, researchers urgently need to quantify the biological effects of these pollutants on the human respiratory system. The AIRCARE study plans to analyze 1,615 lung cancer cases alongside 1,615 control participants. Notably, the team will recruit family members as controls to ensure similar environmental exposure levels within the Delhi-NCR region.
One primary objective of the research is to identify a unique genetic signature within the Indian population. Scientists believe that chronic lung cancer air pollution exposure triggers early molecular changes. These genetic imprints may eventually lead to the development of malignant tumors later in life. By isolating these population-specific markers, the team aims to develop a robust, risk-based screening model. This model will integrate both clinical and molecular components to pinpoint susceptible individuals before the disease reaches advanced stages.
Furthermore, the study utilizes both cohort and case-control designs to track PM 2.5 effects. This dual approach allows researchers to observe how pollution interacts with various demographic and socio-economic factors. Additionally, the study will investigate the multiplicative interaction of air pollution with other known risk factors. Understanding these complex relationships is essential for creating targeted prevention strategies. Ultimately, the data will help identify high-risk groups who require early intervention and more frequent monitoring.
Medical experts are observing a troubling shift in the demographics of lung cancer patients in India. Historically, doctors associated this disease primarily with tobacco use. However, current data indicates a rapid increase in incidence among non-smokers, particularly females and young adults. In some North Indian government hospitals, reports suggest that over 50% of lung cancer cases now occur in individuals who have never smoked. This trend highlights the critical role of environmental toxins in modern oncogenesis.
Air pollution has evolved from an environmental concern into a significant biological threat. Therefore, implementing strict policy and management strategies is essential to mitigate the loss of life. The AIRCARE study provides the necessary evidence to advocate for cleaner air and better healthcare protocols. As lung cancer remains the second most frequent cancer in Indian males, these research findings will be pivotal for future clinical practice and public health advocacy.
Q1: What is the primary objective of the AIRCARE study?
The study aims to investigate the link between chronic exposure to air pollution, specifically PM 2.5, and the risk of developing lung cancer among people in the Delhi-NCR region, focusing on non-smokers.
Q2: Why are family members chosen as controls in this study?
Researchers select family members as controls because they share similar environmental exposure and living conditions, which helps isolate the specific impact of air pollution more accurately than unrelated controls.
Q3: How will the study help in the early detection of lung cancer?
The research will develop a risk-based screening model using clinical and molecular data. This model helps identify highly susceptible individuals, allowing for earlier diagnosis and better treatment outcomes.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


AIIMS-Delhi initiates the AIRCARE study to evaluate how chronic PM 2.5 exposure and genetic signatures contribute to rising lung cancer rates in non-smokers...
6 months ago

As monsoon seasons elevate arboviral disease threats, Tamil Nadu has initiated an ICMR-monitored evaluation of the tetravalent dengue vaccine in Tenkasi district. Clinicians emphasize clinical monitoring, public prevention, and high-quality early pediatric care to reduce disease morbidity across endemic regions.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today